For the R3C group at M21, individuals who presented with clinical malaria before M20 had lower anti-CSP IgG and IgG1 mean levels against CSP antigens, and lower IgG3 levels against CSP FL (p < 0.05 before adjustment). Here, IGHG3 is linked to malaria.